Coric Vlad (CIK 1704317) reported 18 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-06-08). Recent activity: Buy RPRX (4,545 shares), Buy MANE (33,706 shares), Buy MANE (33,706 shares), Buy MANE (148,794 shares), Buy MANE (148,794 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Royalty Pharma plc (RPRX) | Director | Buy | 4,545 | $0 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 33,706 | $0 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 33,706 | $0 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 148,794 | $0 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 148,794 | $0 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 78,075 | $0 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 78,075 | $0 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 117,112 | $0 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 58,823 | $999,991 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 58,823 | $999,991 |
| 2026-01-07 | Biohaven Ltd. (BHVN) | Chief Executive Officer | Buy | 14,250 | $0 |
| 2026-01-07 | Biohaven Ltd. (BHVN) | Chief Executive Officer | Sell | 7,430 | $73,780 |
| 2025-11-17 | Biohaven Ltd. (BHVN) | Chief Executive Officer | Buy | 333,333 | $2.5M |
| 2025-11-17 | Biohaven Ltd. (BHVN) | Chief Executive Officer | Buy | 333,333 | $2.5M |
| 2025-05-14 | Royalty Pharma plc (RPRX) | Director | Buy | 7,614 | $0 |
| 2025-04-21 | Royalty Pharma plc (RPRX) | Director | Buy | 3,184 | $0 |
| 2025-02-06 | Revance Therapeutics, Inc. (RVNC) | Director | Sell | 5,784 | $21,112 |
| 2025-02-06 | Revance Therapeutics, Inc. (RVNC) | Director | Sell | 15,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-08